scholarly article | Q13442814 |
P50 | author | Amrie C Grammer | Q64541552 |
P2093 | author name string | Peter E Lipsky | |
Hermann Girschick | |||
Gabor G Illei | |||
Hanan Gur | |||
Cheryl Yarboro | |||
Randy Fischer | |||
Rebecca Slota | |||
P2860 | cites work | Regulation of CCR6 chemokine receptor expression and responsiveness to macrophage inflammatory protein-3alpha/CCL20 in human B cells | Q24290291 |
CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells | Q24310570 | ||
Perturbations in the impact of mutational activity on Vlambda genes in systemic lupus erythematosus | Q24799961 | ||
Platelet CD40 ligand (CD40L)--subcellular localization, regulation of expression, and inhibition by clopidogrel | Q28181620 | ||
The heterogeneity shown by human plasma cells from tonsil, blood, and bone marrow reveals graded stages of increasing maturity, but local profiles of adhesion molecule expression | Q28204971 | ||
The 1982 revised criteria for the classification of systemic lupus erythematosus | Q29547225 | ||
Cooperation of multiple signaling pathways in CD40-regulated gene expression in B lymphocytes | Q34009928 | ||
CD40-mediated regulation of immune responses by TRAF-dependent and TRAF-independent signaling mechanisms. | Q34082784 | ||
Comparative characteristics of mu chain and alpha chain transcripts expressed by individual tonsil plasma cells. | Q34085624 | ||
Expression of the IRTA1 receptor identifies intraepithelial and subepithelial marginal zone B cells of the mucosa-associated lymphoid tissue (MALT). | Q34217060 | ||
Anti-DNA antibody production by CD5+ and CD5- B cells of patients with systemic lupus erythematosus | Q34240804 | ||
CD40 on human endothelial cells: inducibility by cytokines and functional regulation of adhesion molecule expression. | Q34324146 | ||
Analysis of somatic mutation in five B cell subsets of human tonsil | Q34328629 | ||
CD40 signaling and plaque instability | Q34460843 | ||
Immunoglobulin variable-region gene usage in systemic autoimmune diseases | Q34474688 | ||
The effect of anti-CD40 ligand antibody on B cells in human systemic lupus erythematosus | Q34525244 | ||
CD40-CD40L independent Ig gene hypermutation suggests a second B cell diversification pathway in humans | Q34651496 | ||
CD154-CD40 interactions mediate differentiation to plasma cells in healthy individuals and persons with systemic lupus erythematosus. | Q34736484 | ||
Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis | Q36028683 | ||
Memory B cell development but not germinal center formation is impaired by in vivo blockade of CD40-CD40 ligand interaction | Q36363287 | ||
Activation and homologous desensitization of human endothelial cells by CD40 ligand, tumor necrosis factor, and interleukin 1. | Q36367016 | ||
Expression of stromelysin-3 in atherosclerotic lesions: regulation via CD40-CD40 ligand signaling in vitro and in vivo | Q36367835 | ||
Immunoglobulin kappa chain receptor editing in systemic lupus erythematosus | Q37384441 | ||
Absence of IgD-CD27(+) memory B cell population in X-linked hyper-IgM syndrome | Q39808469 | ||
CD40-mediated regulation of human B-cell responses | Q40395365 | ||
Direct B/B-cell interactions in immunoglobulin synthesis | Q40790000 | ||
Circulating and mitogen-induced immunoglobulin-secreting cells in human peripheral blood: evaluation by a modified reverse hemolytic plaque assay | Q40859333 | ||
Normal human cord blood B cells can produce high affinity IgG antibodies to dsDNA that are recognized by cord blood-derived anti-idiotypic antibodies | Q41290455 | ||
The CD40 ligand expressed by human B cells costimulates B cell responses | Q41345776 | ||
Analysis of CD40-CD40 ligand interactions in the regulation of human B cell function. | Q41500955 | ||
Differentiation and apoptosis of human germinal center B-lymphocytes | Q41522446 | ||
Germinal center development | Q41583265 | ||
Expression of functional CD40 by vascular endothelial cells | Q41981036 | ||
CD40 ligand stimulates proinflammatory cytokine production by human endothelial cells | Q42453856 | ||
Immunohistochemical analysis of human CD5 positive B cells: mantle cells and mantle cell lymphoma are not equivalent in terms of CD5 expression | Q43081419 | ||
Tracking the response of Xid B cells in vivo: TI-2 antigen induces migration and proliferation but Btk is essential for terminal differentiation | Q43682640 | ||
Naive and memory B cells respond differentially to T-dependent signaling but display an equal potential for differentiation toward the centroblast-restricted CD77/globotriaosylceramide phenotype | Q44481496 | ||
Cyclophosphamide use in a young woman with antiphospholipid antibodies and recurrent cerebrovascular accident. | Q44523327 | ||
Role of CD154 in the secondary immune response: the reduction of pre-existing splenic germinal centers and anti-factor VIII inhibitor titer | Q45871130 | ||
Spontaneous formation of germinal centers in autoimmune mice. | Q47574161 | ||
Heterogeneity of tonsillar subepithelial B lymphocytes, the splenic marginal zone equivalents | Q47859763 | ||
Visualization of specific B and T lymphocyte interactions in the lymph node | Q47892330 | ||
Correlation between circulating CD27high plasma cells and disease activity in patients with systemic lupus erythematosus | Q47913418 | ||
CD154 stimulation of interleukin-12 synthesis in human endothelial cells | Q48747669 | ||
Increased frequency of pre-germinal center B cells and plasma cell precursors in the blood of children with systemic lupus erythematosus. | Q52018240 | ||
Expression, regulation, and function of B cell-expressed CD154 in germinal centers. | Q52031799 | ||
Bidirectional regulation of human B cell responses by CD40-CD40 ligand interactions. | Q52042854 | ||
Subepithelial B cells in the human palatine tonsil. I. Morphologic, cytochemical and phenotypic characterization. | Q52046695 | ||
Generation of memory B cells and plasma cells in vitro. | Q52053106 | ||
Immunohistologic analysis of ineffective CD40-CD40 ligand interaction in lymphoid tissues from patients with X-linked immunodeficiency with hyper-IgM. Abortive germinal center cell reaction and severe depletion of follicular dendritic cells. | Q52507744 | ||
A humanized anti-human CD154 monoclonal antibody blocks CD154-CD40 mediated human B cell activation. | Q52843789 | ||
Enhanced mutational activity and disturbed selection of mutations in V(H) gene rearrangements in a patient with systemic lupus erythematosus. | Q52928524 | ||
The inflammatory action of CD40 ligand (CD154) expressed on activated human platelets is temporally limited by coexpressed CD40. | Q52962713 | ||
Cellular interaction in germinal centers. Roles of CD40 ligand and B7-2 in established germinal centers. | Q54167674 | ||
Enforced and prolonged CD40 ligand expression triggers autoantibody productionin vivo | Q57058957 | ||
Activated platelets induce tissue factor expression on human umbilical vein endothelial cells by ligation of CD40 | Q62604578 | ||
Analysis of the expression of CD5 by human B cells and correlation with functional activity | Q67530817 | ||
Generation of nondividing high rate Ig-secreting plasma cells in cultures of human B cells stimulated with anti-CD3-activated T cells | Q68052233 | ||
Identification of early plasma cells in peripheral blood and their clinical significance | Q70902003 | ||
Identification of a tonsil IgD+ B cell subset with phenotypical and functional characteristics of germinal center B cells | Q71420869 | ||
The role of CD40-CD40 ligand interaction in human T cell-B cell collaboration | Q71633051 | ||
Independent expression of autoantibodies in systemic lupus erythematosus | Q72119151 | ||
The role of B cell proliferation in the generation of immunoglobulin-secreting cells in man | Q72698516 | ||
Inhibition of agonist-induced p42 and p38 mitogen-activated protein kinase phosphorylation and CD40 ligand/P-selectin expression by cyclic nucleotide-regulated pathways in human platelets | Q73011668 | ||
CD5-positive and CD5-negative human B cells converge to an indistinguishable population on signalling through B-cell receptors and CD40 | Q73024047 | ||
CD4+ T lymphocytes with constitutive CD40 ligand in preautoimmune (NZB x NZW)F1 lupus-prone mice: phenotype and possible role in autoreactivity | Q73084836 | ||
A short course of BG9588 (anti-CD40 ligand antibody) improves serologic activity and decreases hematuria in patients with proliferative lupus glomerulonephritis | Q73114791 | ||
Disturbed peripheral B lymphocyte homeostasis in systemic lupus erythematosus | Q73163240 | ||
Age-associated changes in the cellular composition of the human adenoid | Q73228982 | ||
Macrophages, smooth muscle cells, endothelial cells, and T-cells express CD40 and CD40L in fatty streaks and more advanced human atherosclerotic lesions. Colocalization with epitopes of oxidized low-density lipoprotein, scavenger receptor, and CD16 | Q73245727 | ||
B cells lacking RP105, a novel B cell antigen, in systemic lupus erythematosus | Q73313524 | ||
Expression of CD40 in vascular smooth muscle cells and macrophages is associated with early development of human atherosclerotic lesions | Q73344118 | ||
CD154 (CD40L) induces human endothelial cell chemokine production and migration of leukocyte subsets | Q73386215 | ||
Phase I clinical trial of a monoclonal antibody against CD40-ligand (IDEC-131) in patients with systemic lupus erythematosus | Q73483737 | ||
In vitro stimulation of human tonsillar subepithelial B cells: requirement for interaction with activated T cells | Q73592478 | ||
The influence of CD40-CD154 interactions on the expressed human V(H) repertoire: analysis of V(H) genes expressed by individual B cells of a patient with X-linked hyper-IgM syndrome | Q73849956 | ||
The role of CD40-CD40 ligand (CD154) interactions in immunoglobulin light chain repertoire generation and somatic mutation | Q74050992 | ||
Biological function of CD40 on human endothelial cells: costimulation with CD40 ligand and interleukin-4 selectively induces expression of vascular cell adhesion molecule-1 and P-selectin resulting in preferential adhesion of lymphocytes | Q74121901 | ||
CD40L-CD40 interactions regulate endothelial cell surface tissue factor and thrombomodulin expression | Q74310001 | ||
Spontaneous immunoglobulin-producing capacity of cultures from lupus patients and normal donors following depletion of cells expressing CD19 or CD38 | Q74404692 | ||
Systemic lupus erythematosus: an autoimmune disease of B cell hyperactivity | Q74433998 | ||
Inflamed kidneys of NZB / W mice are a major site for the homeostasis of plasma cells | Q74460576 | ||
A periarteriolar lymphoid sheath-associated B cell focus response is not observed during the development of the anti-arsonate germinal center reaction | Q74463455 | ||
CD40 engagement on endothelial cells promotes tissue factor-dependent procoagulant activity | Q74604970 | ||
Cutting Edge: Ectopic expression of CD40 ligand on B cells induces lupus-like autoimmune disease | Q77373855 | ||
Fas expression on peripheral blood lymphocytes in systemic lupus erythematosus (SLE): relation to lymphocyte activation and disease activity | Q77479812 | ||
Enhanced mutational activity of Vkappa gene rearrangements in systemic lupus erythematosus | Q78116887 | ||
CD40 ligation induced phenotypic and functional expression of CD80 by human cardiac microvascular endothelial cells | Q78164667 | ||
Treatment of systemic lupus erythematosus by inhibition of T cell costimulation with anti-CD154: a randomized, double-blind, placebo-controlled trial | Q78667363 | ||
P433 | issue | 10 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | systemic lupus erythematosus | Q1485 |
lupus erythematosus | Q188297 | ||
P304 | page(s) | 1506-1520 | |
P577 | publication date | 2003-11-01 | |
P1433 | published in | Journal of Clinical Investigation | Q3186904 |
P1476 | title | Abnormal germinal center reactions in systemic lupus erythematosus demonstrated by blockade of CD154-CD40 interactions | |
P478 | volume | 112 |